Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemicDamian Santomauro(Park Centre for Mental Health), Alize J Ferrari(Park Centre for Mental Health)The LancetOctober 9, 202110.1016/s0140-6736(21)02143-7Cited by 5,293SaveCiteExport RISWatch citationsRelated PapersGlobal, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015|The Lancet|2016|7.8kGlobal, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015|The Lancet|2016|7.4kGlobal incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021|The Lancet|2024|4.4kGlobal and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013|JAMA Pediatrics|2016|632Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023|The Lancet|2025|386